Skip to main content

Day: December 13, 2023

SRM Kicks-Off 2024 Sip with Me Marketing Campaign

SipWithMeCup.com Social Media Advertising Campaign Atlanta, Dallas & Las Vegas Trade Shows JUPITER, FL, Dec. 13, 2023 (GLOBE NEWSWIRE) — SRM Entertainment, Inc. (Nasdaq: SRM) (the “Company” or “SRM”) is a trusted toy and souvenir designer and developer, selling into the world’s largest theme parks and entertainment venues, is launching their 2024 Sip with Me marketing campaign which includes social media ads, a consumer SipWithMeCup.com website and wholesale trade shows in Atlanta, Dallas and Las Vegas. SRM continues to drive consumer brand awareness of Sip with Me® patented children’s cups featuring Smurfs & Zoonicorn franchise characters alongside SRM’s proprietary, loveable Trend Animal collection. SRM is launching its consumer Sip with Me social media advertising campaign on Meta and Tik Tok along with the debut of...

Continue reading

SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts

DENVER, Dec. 13, 2023 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of dysregulated immune responses including hyperinflammation on vital organs, announces the formation of the SeaStar Medical Scientific Advisory Board (SAB). The SAB is comprised of world-renowned international pediatric and adult clinical experts including nephrologists, critical care intensivists and translational scientists who will advise on the Company’s technology capabilities, share insights on emerging trends in healthcare, and advise on the Company’s critical care and acute kidney injury (AKI) clinical development programs. “Science and innovation are the foundational pillars of SeaStar Medical and key to our competitive advantage,” said Eric Schlorff,...

Continue reading

CISO Global Successfully Completes SOC 2 Audit

Independent Audit Validates CISO Global Security Controls and Data Privacy Practices Scottsdale, Ariz., Dec. 13, 2023 (GLOBE NEWSWIRE) — CISO Global (NASDAQCM: CISO), an industry leader as a managed cybersecurity and compliance provider, today announced the successful completion of its SOC 2 Type II audit following a 12-month review period. Conducted by leading compliance assessor A-LIGN, a technology-enabled security and compliance partner, the audit validates its security controls and data privacy practices of the audited company align with the highest standards. “CISO Global clients entrust us to manage their data securely and safely,” said David Jemmett, CEO of CISO Global. “Knowing that we are SOC 2 compliant gives our clients that extra peace of mind that their data is fully protected, and our security and data privacy controls...

Continue reading

SELLAS to Host Corporate Update Webinar on January 3, 2024 at 8:30 am ET

NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that it will host a corporate update webinar on Wednesday, January 3, 2024, at 8:30 a.m. Eastern Time. Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS, will discuss the Company’s achievements in 2023 and provide an outlook for 2024. Dr. Stergiou will be joined by two key opinion leaders and principal investigators who will discuss the Phase 3 registrational REGAL clinical trial of galinpepimut-S (GPS) in patients with acute myeloid leukemia and the clinical program for SLS009, the Company’s CDK9 inhibitor: Dr. Panagiotis Tsirigotis,...

Continue reading

BIGG Digital Assets, Inc. Wholly Owned Subsidiary TerraZero Technologies, Inc. and Paidia Gaming Announce Strategic Partnership to Pioneer the Next Era of Self-Expression Across the Internet with TerraZero’s ‘Intraverse’

VANCOUVER, British Columbia, Dec. 13, 2023 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, and Blockchain Intelligence Group and TerraZero is pleased to report that Paidia Gaming (“Paidia”), a women-led gaming, tech and media company and an innovator in the gaming industry, and TerraZero Technologies Inc. (“TerraZero”), a vertically integrated digital experience development group and leading web3 technology company specializing in helping brands create immersive virtual environments, proudly announce their strategic partnership aimed at revolutionizing self-expression across the Internet. This collaboration brings together Paidia’s expertise in creating products and experiences for gamers...

Continue reading

JIN MEDICAL INTERNATIONAL LTD. Empowers “Lao Le Hui” Assisted Bathing Project with Portable Nano-thermal Therapy Bath

Changzhou City, China, Dec. 13, 2023 (GLOBE NEWSWIRE) — JIN MEDICAL INTERNATIONAL LTD. (the “Company” or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced the Company’s portable nano-thermal therapy bath has been selected as the equipment for “Lao Le Hui” Assisted Bathing Project (the “Project”). This significant initiative is a collaborative effort between a recognized foundation for the elderly in Shanghai, prominent state-owned enterprises, and industry partners, with the noble purpose of providing compassionate care and assistance to disabled or semi-disabled elderly individuals residing in Shanghai. Over the next two years, the Project aims to serve an impressive goal of 100,000...

Continue reading

SATO Corporation’s Board of Directors has made a decision on a share issue

SATO CORPORATION Stock Exchange Release 13 December 2023 at 3:30 pm NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, SOUTH AFRICA, SINGAPORE, JAPAN, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. SATO Corporation (the “Company“) announced on 20 November 2023 that the Company is planning a share issue of up to EUR 200 million to strengthen its equity ratio. Today on 13 December 2023, with the authorisation granted by the Extraordinary General Meeting on 11 December 2023, the Board of Directors of the Company has decided on an offering in which the Company issues up to 28,308,533 new shares in the Company (the “Offer Shares”) in accordance with the terms and conditions of the rights offering to the Company’s...

Continue reading

BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

POMPANO BEACH, Fla., Dec. 13, 2023 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board. Mr. Dugan brings a wealth of experience to BioStem, with proven, hands-on expertise as a senior executive who has transformed businesses, established new market opportunities, and driven growth in the face of strong competition. He has extensive experience in the wound care and surgical fields. BioStem Technologies CEO, Jason Matuszewski, said, “I am delighted to welcome Mr. Dugan to BioStem’s Board of Directors. We look forward to benefiting from his extensive leadership and industry experience...

Continue reading

Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome

Positive initial data and clean safety profile catalyze optimization planSize of both ongoing clinical trials significantly increasedLower dose eliminated from blinded trialDosing frequency changed to twice-daily from once-daily for both trials ASHBURN, Va., Dec. 13, 2023 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced that it has received U.S. Food and Drug Administration (FDA) clearance to implement a number of protocol amendments to its two ongoing clinical trials for QRX003, which is being developed as a potential treatment for Netherton Syndrome (NS). Both trials are being conducted under Quoin’s open Investigational New Drug Application (IND) for QRX003. “We are extremely pleased to announce clearance...

Continue reading

GEMXX Corporation Provides Corporate Update on Recent Milestones and Expansion Plans for 2024

The Company is highlighting recent significant achievements to update new and existing investors prior to the holiday season. LAS VEGAS, Dec. 13, 2023 (GLOBE NEWSWIRE) — via IBN — GEMXX Corporation (OTC: GEMZ) (“GEMXX” or the “Company”), a leader in the ammolite gemstone mine-to-market segment and a partner in Canadian gold exploration Company Crazy Horse Mining, Inc. (“CHMI” or “Crazy Horse”) today provides the following updates: Current StateGEMXX has achieved significant milestones recently, and it’s worth noting that the Company continues to control each stage of its production, including gold mining, gemstone production, jewelry manufacturing and global distribution. Further, the Company continues to expand while avoiding long-term debt. Jay Maull, GEMXX CEO, said: “We are tremendously pleased with the development...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.